CM
GILD icon

Columbus Macro’s Gilead Sciences GILD Stock Holding History

Columbus Macro’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
21,700
-227
-1% -$29.9K 0.27% 108
2026
Q1 		$3.06M Sell
21,927
-771
-3% -$108K 0.33% 96
2025
Q4 		$2.79M Sell
22,698
-1,268
-5% -$154K 0.31% 101
2025
Q3 		$2.66M Sell
23,966
-520
-2% -$59.1K 0.3% 102
2025
Q2 		$2.71M Buy
24,486
+468
+2% +$49.8K 0.33% 97
2025
Q1 		$2.69M Sell
24,018
-1,085
-4% -$112K 0.35% 99
2024
Q4 		$2.32M Buy
25,103
+9,004
+56% +$811K 0.32% 106
2024
Q3 		$1.35M Sell
16,099
-344
-2% -$26.2K 0.49% 73
2024
Q2 		$1.13M Buy
16,443
+668
+4% +$44.6K 0.44% 82
2024
Q1 		$1.16M Sell
15,775
-807
-5% -$62.1K 0.44% 80
2023
Q4 		$1.36M Buy
+16,582
New +$1.29M 0.54% 67
2021
Q4 		– Sell
-19,881
Closed -$1.39M – 168
2021
Q3 		$1.39M Sell
19,881
-593
-3% -$41.7K 0.46% 68
2021
Q2 		$1.41M Sell
20,474
-253
-1% -$16.9K 0.44% 68
2021
Q1 		$1.34M Sell
20,727
-3,539
-15% -$228K 0.42% 69
2020
Q4 		$1.41M Sell
24,266
-1,629
-6% -$98.3K 0.43% 66
2020
Q3 		$1.64M Sell
25,895
-8,056
-24% -$559K 0.5% 65
2020
Q2 		$2.61M Sell
33,951
-1,866
-5% -$143K 0.71% 45
2020
Q1 		$2.68M Sell
35,817
-2,940
-8% -$203K 0.78% 38
2019
Q4 		$2.52M Sell
38,757
-10,484
-21% -$683K 0.56% 53
2019
Q3 		$3.12M Sell
49,241
-22,176
-31% -$1.45M 0.78% 48
2019
Q2 		$4.83M Sell
71,417
-751
-1% -$49.4K 1.04% 37
2019
Q1 		$4.69M Buy
72,168
+1,553
+2% +$103K 1.03% 41
2018
Q4 		$4.42M Buy
70,615
+1,232
+2% +$86.1K 1.01% 40
2018
Q3 		$5.36M Buy
69,383
+5,969
+9% +$451K 1.33% 26
2018
Q2 		$4.49M Buy
+63,414
New +$4.48M 1.17% 34

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Columbus Macro's GILD Position: Q2 2026 in Review

Columbus Macro reduced its Gilead Sciences (GILD) stake by 1% in Q2 2026, selling an estimated $29.9K and leaving 21,700 shares worth $2.74M. The position accounts for 0.27% of the portfolio, ranked #108.

Columbus Macro first reported a position in GILD in Q2 2018 and has held it in 25 quarters since. The position peaked at $5.36M in Q3 2018. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Columbus Macro held 21,700 shares of Gilead Sciences worth $2.74M as of Q2 2026.
  • Columbus Macro sold 227 Gilead Sciences shares in Q2 2026, an estimated $29.9K.
  • Gilead Sciences made up 0.27% of Columbus Macro's portfolio in Q2 2026, its #108 holding.
  • Columbus Macro first reported a position in Gilead Sciences in Q2 2018 and has held it in 25 quarters since.
  • Columbus Macro's Gilead Sciences position peaked at $5.36M in Q3 2018.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Columbus Macro's 13F filing for Q2 2026, filed 22 Jul 2026.